JP2006124350A - Nmf production promoter - Google Patents
Nmf production promoter Download PDFInfo
- Publication number
- JP2006124350A JP2006124350A JP2004317529A JP2004317529A JP2006124350A JP 2006124350 A JP2006124350 A JP 2006124350A JP 2004317529 A JP2004317529 A JP 2004317529A JP 2004317529 A JP2004317529 A JP 2004317529A JP 2006124350 A JP2006124350 A JP 2006124350A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- nmf
- production
- added
- apricot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 88
- 239000000284 extract Substances 0.000 claims abstract description 64
- 244000018633 Prunus armeniaca Species 0.000 claims abstract description 29
- 235000009827 Prunus armeniaca Nutrition 0.000 claims abstract description 29
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 8
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 25
- 244000144730 Amygdalus persica Species 0.000 claims description 23
- 241000242583 Scyphozoa Species 0.000 claims description 21
- 240000005979 Hordeum vulgare Species 0.000 claims description 19
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 19
- 210000000434 stratum corneum Anatomy 0.000 claims description 13
- 210000003491 skin Anatomy 0.000 claims description 12
- 235000011960 Brassica ruvo Nutrition 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 241000205585 Aquilegia canadensis Species 0.000 claims 4
- 241000237502 Ostreidae Species 0.000 claims 1
- 235000020636 oyster Nutrition 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 6
- 238000001035 drying Methods 0.000 abstract description 5
- 230000014759 maintenance of location Effects 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 210000001339 epidermal cell Anatomy 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 241000382455 Angelica sinensis Species 0.000 abstract description 2
- 244000077995 Coix lacryma jobi Species 0.000 abstract description 2
- 235000007354 Coix lacryma jobi Nutrition 0.000 abstract description 2
- 240000002045 Guettarda speciosa Species 0.000 abstract description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 2
- 240000002817 Leonurus sibiricus Species 0.000 abstract description 2
- 235000002434 Leonurus sibiricus Nutrition 0.000 abstract description 2
- 244000167230 Lonicera japonica Species 0.000 abstract description 2
- 235000017617 Lonicera japonica Nutrition 0.000 abstract description 2
- 241001092459 Rubus Species 0.000 abstract description 2
- 241000908178 Tremella fuciformis Species 0.000 abstract description 2
- 208000003251 Pruritus Diseases 0.000 abstract 2
- 241000894007 species Species 0.000 abstract 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 58
- 239000000203 mixture Substances 0.000 description 50
- 238000009472 formulation Methods 0.000 description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 43
- 239000000469 ethanolic extract Substances 0.000 description 33
- 229940058015 1,3-butylene glycol Drugs 0.000 description 28
- 235000019437 butane-1,3-diol Nutrition 0.000 description 28
- 239000008213 purified water Substances 0.000 description 25
- 239000006071 cream Substances 0.000 description 23
- -1 etc.) Natural products 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 18
- 241001570521 Lonicera periclymenum Species 0.000 description 16
- 235000019441 ethanol Nutrition 0.000 description 16
- 239000007864 aqueous solution Substances 0.000 description 11
- 241000269959 Xiphias gladius Species 0.000 description 10
- 235000021335 sword fish Nutrition 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000003826 tablet Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 239000006286 aqueous extract Substances 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 239000008187 granular material Substances 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 102100028314 Filaggrin Human genes 0.000 description 7
- 101710088660 Filaggrin Proteins 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 5
- 241000286209 Phasianidae Species 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 239000003788 bath preparation Substances 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 230000036620 skin dryness Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000009538 yokuinin Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 108700041153 Filaggrin Proteins Proteins 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 241001125831 Istiophoridae Species 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 240000005809 Prunus persica Species 0.000 description 2
- 235000004789 Rosa xanthina Nutrition 0.000 description 2
- 241000220222 Rosaceae Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 108010075526 keratohyalin Proteins 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 241000242764 Aequorea victoria Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、新規なNMF産生促進剤に関し、特に表皮顆粒層に存在する表皮細胞におけるNMFの産生を促進することにより角質層の保湿機能を改善し、乾燥に由来するカユミ、小ジワ、肌荒れ等を改善する皮膚外用剤に関する。 The present invention relates to a novel NMF production promoter, and in particular, improves the moisturizing function of the stratum corneum by promoting the production of NMF in epidermal cells present in the epidermal granule layer, resulting in dryness-causing, wrinkles, rough skin, etc. The present invention relates to an external preparation for skin.
角質層の保湿性に重要な役割を果たしているのがNMFであることは古くから知られており、これまでNMF成分は保湿剤の開発に応用されてきた。角質層におけるNMFの減少は、その保湿性を低下させ乾燥を招く。その結果として乾燥性のカユミが引き起こされる。近年、NMFの主体をなすアミノ酸は、ケラトヒアリン顆粒の主成分であるフィラグリンというタンパク質の分解により産生されることが明らかとなった(非特許文献1)。すなわち、表皮顆粒層において合成されたプロフィラグリンはケラトヒアリン顆粒に蓄積された後、顆粒層上層から角質層に至る過程で脱リン酸、加水分解を経てフィラグリンに分解される。さらにフィラグリンは角質層上層に至る過程でアミノ酸に分解されNMFの主体となる。一方、乾燥肌を呈する病態とフィラグリンに関する研究が進められ、老人性乾皮症やアトピー性皮膚炎などの角質層中ではアミノ酸が減少していることが知られているが、それらの皮膚ではフィラグリンの発現が低下していることが明らかにされている(非特許文献2、3)。したがって、角質層の保湿性維持の目的でNMFの産生を高めるためにはケラチノサイトにおけるフィラグリンあるいはプロフィラグリンの生成促進が重要であると考えられるようになり、特許文献1〜3などの植物成分を用いたフィラグリンあるいはプロフィラグリンの生成促進剤が報告されている。一方、メハジキ、アンズ、スイカズラ、サイシン、トウキ、ハトムギ、モモ、テンチャおよびシロキクラゲの抽出物のNMF産生促進効果、角質層保湿機能改善効果、肌の保水能力改善効果およびカユミ改善効果については知られていない。
上述のようにフィラグリンあるいはプロフィラグリンの生成を促進し、角質層中のNMF量を上昇させ保湿能を高める植物成分が提案されているが、NMFの産生を促進することで健康な皮膚状態を維持する作用を持つ他の物質または化合物の提供は依然として望まれている。 As described above, plant components that promote the production of filaggrin or profilagrin, increase the amount of NMF in the stratum corneum, and enhance the moisture retention ability have been proposed, but maintaining a healthy skin state by promoting the production of NMF It is still desirable to provide other substances or compounds that have the effect of
上記実情に鑑み、本発明者らは、表皮ケラチノサイトのNMF産生を促進するNMF産生促進剤を見出すべく誠意研究を行った結果、メハジキ、アンズ、スイカズラ、サイシン、トウキ、ハトムギ、モモ、テンチャおよびシロキクラゲの抽出物がその目的に合致することを見出し、さらには、角質層保湿機能改善効果、肌の保水能力改善効果およびカユミ改善効果についても見出すことによって本発明を完成した。 In view of the above circumstances, the present inventors conducted an sincere study to find an NMF production promoter that promotes NMF production of epidermal keratinocytes. As a result, the present inventors have found that Japanese pheasant, apricot, honeysuckle, saishin, touki, pearl barley, peach, tencha, and white jellyfish. The present invention has been completed by finding that the extract of No. 1 meets the purpose, and further finding out the effect of improving the moisturizing function of the stratum corneum, the effect of improving the water retaining ability of the skin, and the effect of improving the skin.
すなわち、本発明は、メハジキ、アンズ、スイカズラ、サイシン、トウキ、ハトムギ、モモ、テンチャおよびシロキクラゲから選ばれる一種または二種以上の抽出物を含有することを特徴とするNMF産生促進剤、角質層保湿機能改善剤、保水能力改善用皮膚外用剤およびカユミ改善用皮膚外用剤に関するものである。 That is, the present invention comprises an NMF production promoter, stratum corneum moisturizing agent, characterized by containing one or more extracts selected from swordfish, apricot, honeysuckle, saishin, touki, pearl barley, peach, tencha and white jellyfish The present invention relates to a function improving agent, a skin external preparation for improving water retention ability, and a skin external preparation for improving hair stain.
本発明で用いられるメハジキ(学名:Leonurus sibiricus L.)は、シソ科メハジキ属に属する草本で、本州、四国、九州、朝鮮及び中国から東南アジアにかけて山野の日当りの良い場所に自生する。メハジキの地上部の全草は益母草(ヤクモソウ)の名称で、また、成熟果実がじゅう蔚子(ジュウイシ)の名称として流通しているので使用できる。 The pheasant used in the present invention (scientific name: Leonurus sibiricus L.) is a herb belonging to the genus Lamiaceae, and grows naturally in sunny places in Yamano from Honshu, Shikoku, Kyushu, Korea and China to Southeast Asia. The whole grass of Mejijiki can be used because it is distributed under the name of Yakumosou, and the mature fruit is distributed under the name of Jujushi.
本発明で用いられるアンズは、バラ科に属するホンアンズ(学名:Prunus armeniaca L)、アンズ(学名:Prunus armeniaca L.var.ansu Maximowicz)又はその他近縁植物で、中国、日本に広く分布する。種子を乾燥したもの(生薬名:杏仁)などを利用することができる。 The apricot used in the present invention is a horn apricot (Prunus armenica L), apricot (Prunus armenica L. var. Ansu Maximowicz) or other related plant belonging to the Rosaceae family, and is widely distributed in China and Japan. A dried seed (herbal medicine name: Anjin) can be used.
本発明で用いられるスイカズラは、スイカズラ科に属するスイカズラ(学名:Lonicera japonica Thinberg)又はその他同属植物であり、日本や中国などに自生するツル性の植物である。枝ごと摘み刻むか、または葉だけを摘み取り乾燥したもの(生薬名:忍冬)や花部を乾燥したもの(生薬名:金銀花)などを利用することができる。 The honeysuckle used in the present invention is a honeysuckle (scientific name: Lonicera japonica Thinberg) belonging to the family Lonicera or other genus plants, and is a creeping plant that grows naturally in Japan, China, and the like. It is possible to use things that are picked and chopped with branches, or leaves that are picked and dried (herbal medicine name: Shinobu) or dried flower parts (herbal medicine name: gold and silver flowers).
本発明で用いられるサイシンは、ウマノスズクサ科に属するケイリンサイシン(学名:Asiasarum heterotropoides F.)またはウスバサイシン(学名:Asiasarum sieboldi F.)であり、根茎および根、または根つき全草を乾燥したもの(細辛)などを利用することができる。 Saisin used in the present invention is Keirinsaicin (scientific name: Asiasarum heterotropoids F.) or Usbasaicin (scientific name: Asiasarum sieboldi F.) belonging to the family Umanosaceae, which is obtained by drying rhizomes and roots, or rooted whole plants ( Can be used.
本発明で用いられるトウキは、セリ科に属するカラトウキ(学名:Angelica sinensis Diels)、トウキ(学名:Angelica acutioba Kitagawa)又はその他同属植物であり、根を乾燥したもの(生薬名:当帰)などを利用することができる。 The touki used in the present invention is a tomato (scientific name: Angelica sinensis Diels), Toki (scientific name: Angelica acutiba Kitagawa) or other same genus plant belonging to the celery family, dried roots (name of herbal medicine: Toki), etc. Can be used.
本発明で用いられるハトムギ(学名:Coix lacryma−jobi Linne var. ma−yuen Stapf)は、イネ科に属する草本であり、種皮を除いた成熟種子を乾燥したもの(生薬名:ヨクイニン)などを利用することができる。 The barley used in the present invention (scientific name: Coix lacryma-jobi Linne var. Ma-yuen Stapf) is a herb belonging to the family Gramineae, and is obtained by drying mature seeds excluding seed coats (herbal medicine name: Yokuinin) can do.
本発明で用いられるモモは、バラ科に属するモモ(学名:Prumus persica Batsch)、ノモモ(学名:Prumus persica Batsch var davidana Maximowicz)又はその他同属植物である。成熟した種子を乾燥したもの(生薬名:桃仁)などを利用することができる。 The peach used in the present invention is a peach (Scientific name: Prumus persica Batsch), a peach (Scientific name: Prumus persica Batsch var davidana Maximovic), or other plants belonging to the same genus. Dry seeds from matured seeds (namely, herbal medicine: peach seed) can be used.
本発明で用いられるテンチャ(学名:Rubus suavissimus Shugan Lee)は、バラ科に属し、中国南西部の山岳地帯にのみ産し、開胃茶とも呼ばれ、食欲増進、去痰、咳止めとして用いられている。葉を乾燥したもの(生薬名:甜茶)などを利用することができる。 Tencha (scientific name: Rubus suavissimus Shugan Lee) used in the present invention belongs to the family Rosaceae, is produced only in the mountainous area of southwestern China and is also called open stomach tea and is used as an appetite booster, expectorant, cough . The dried leaves (herbal medicine name: tea) can be used.
本発明で用いられるシロキクラゲ(学名:Tremella fuciformis B.)は、シロキクラゲ科に属するキノコで、子実体、菌体などを利用することができる。 The white jellyfish used in the present invention (scientific name: Tremella fuciformis B.) is a mushroom belonging to the family Asteraceae, and can use fruit bodies, fungus bodies, and the like.
また、本発明で使用するメハジキ、アンズ、スイカズラ、サイシン、トウキ、ハトムギ、モモ、テンチャおよびシロキクラゲの抽出物は、例えば、植物を抽出溶媒と共に浸漬または加熱した後、濾過し、必要ならば濃縮して得られる。抽出溶媒としては、例えば、水、低級1価アルコール類(メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール等)、液状多価アルコール(1,3−ブチレングリコール、プロピレングリコール等)、炭化水素(ヘキサン、ペンタン等)、ケトン類(アセトン、メチルエチルケトン等)、エーテル類(エチルエーテル、テトラヒドロフラン、プロピルエーテル等)、アセトニトリル等があげられる。これらの溶媒は単独で用いても2種以上を混合して用いてもよい。好ましくは、水あるいは水溶性溶媒(水と任意の割合で混合可能な溶媒。例えば、エタノール、1,3−ブチレングリコール、プロピレングリコール等)のうち1種または2種以上の溶媒を用いるのがよい。抽出物はそのまま用いてもよいし、溶媒を一部、または全部留去して用いてもよい。 In addition, for example, the extract of swordfish, apricot, honeysuckle, saishin, touki, pearl barley, peach, tencha, and white jellyfish used in the present invention is soaked or heated with an extraction solvent, filtered, and concentrated if necessary. Obtained. Examples of the extraction solvent include water, lower monohydric alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (1,3-butylene glycol, propylene). Glycol, etc.), hydrocarbons (hexane, pentane, etc.), ketones (acetone, methyl ethyl ketone, etc.), ethers (ethyl ether, tetrahydrofuran, propyl ether, etc.), acetonitrile and the like. These solvents may be used alone or in combination of two or more. Preferably, one or two or more of water or a water-soluble solvent (solvent that can be mixed with water in an arbitrary ratio. For example, ethanol, 1,3-butylene glycol, propylene glycol, etc.) may be used. . The extract may be used as it is, or a part or all of the solvent may be distilled off.
本発明に関わるNMF産生促進剤を上記の目的で用いるには、通常全身的または局所的に投与される。投与方法としては、経口投与または経皮投与などが挙げられる。投与量は、年齢、体重、症状、治療効果、投与方法、処理時間などにより異なるが、通常成人1人当たり1回に1mg〜1g、好ましくは20mg〜200mgの範囲で1日1回から数回投与される。もちろん前記したように、投与量は種々の条件で変動するので、上記投与範囲より少ない量で十分な場合もあるし、また、範囲を超えて投与する必要のある場合もある。 In order to use the NMF production promoter according to the present invention for the above purpose, it is usually administered systemically or locally. Examples of the administration method include oral administration and transdermal administration. The dose varies depending on age, body weight, symptoms, therapeutic effect, administration method, treatment time, etc., but is usually 1 mg to 1 g per adult, preferably 20 mg to 200 mg once to several times a day. Is done. Of course, as described above, since the dosage varies depending on various conditions, an amount smaller than the above-mentioned administration range may be sufficient, or it may be necessary to administer beyond the range.
本発明のNMF産生促進剤には、上記抽出物をそのまま使用しても良く、抽出物の効果を損なわない範囲内で、希釈剤を用いることもできる。希釈剤としては固体、液体、半固体でも良く、例えば、次のものが挙げられる。すなわち、賦形剤、増量剤、結合剤、湿潤剤、崩壊剤、界面活性剤、滑沢剤、分散剤、緩衝剤、香料、保存料、溶解補助剤、溶剤などである。具体的には、乳糖、ショ糖、ソルビット、マンニット、澱粉、沈降性炭酸カルシウム、重質酸化マグネシウム、タルク、ステアリン酸カルシウム、ステアリン酸マグネシウム、セルロースまたはその誘導体、アミロペクチン、ポリビニルアルコール、ゼラチン、界面活性剤、水、生理食塩水、エタノール、グリセリン、プロピレングリコール、カカオ脂、ラウリン脂、ワセリン、パラフィン、高級アルコールなどである。 In the NMF production promoter of the present invention, the above extract may be used as it is, and a diluent may be used within a range not impairing the effect of the extract. The diluent may be a solid, liquid, or semi-solid, and examples include the following. That is, excipients, extenders, binders, wetting agents, disintegrants, surfactants, lubricants, dispersants, buffers, fragrances, preservatives, solubilizers, solvents, and the like. Specifically, lactose, sucrose, sorbit, mannitol, starch, precipitated calcium carbonate, heavy magnesium oxide, talc, calcium stearate, magnesium stearate, cellulose or derivatives thereof, amylopectin, polyvinyl alcohol, gelatin, surface activity Agents, water, physiological saline, ethanol, glycerin, propylene glycol, cacao butter, laurin butter, petrolatum, paraffin, higher alcohol and the like.
本発明に用いるNMF産生促進剤は、食品、化粧品、医薬部外品または医薬品のいずれにも用いることができ、その剤型としては、例えば、錠菓、飲料、化粧水、クリーム、乳液、ゲル剤、エアゾール剤、軟膏、パップ剤、ペースト剤、プラスター剤、エッセンス、パック、洗浄剤、浴用剤、ファンデーション、打粉、口紅、散剤、丸剤、錠剤、注射剤、坐剤、乳剤、カプセル剤、顆粒剤、液剤(チンキ剤、流エキス剤、酒精剤、懸濁剤、リモナーデ剤などを含む)等が挙げられる。 The NMF production promoter used in the present invention can be used in any of foods, cosmetics, quasi-drugs, and pharmaceuticals. Examples of the dosage form include tablet confectionery, beverages, lotions, creams, emulsions, gels. Agent, aerosol, ointment, poultice, paste, plaster, essence, pack, cleaning agent, bath preparation, foundation, powder, lipstick, powder, pill, tablet, injection, suppository, emulsion, capsule, Granules, liquids (including tinctures, fluid extracts, spirits, suspensions, limonades, etc.).
本発明に用いるメハジキ、アンズ、スイカズラ、サイシン、トウキ、ハトムギ、モモ、テンチャおよびシロキクラゲの抽出物の配合量は特に限定されないが、乾燥物として0.0001〜75重量%の範囲が好ましく、さらに好ましくは0.001〜30重量%である。0.0001重量%以下では効果が低く、また75重量%を超えても効果に大きな増強はみられにくく、効率的でない。また、添加の方法については、予め加えておいても製造途中で添加しても良く、作業性を考えて適宜選択すれば良い。 The blending amount of the extract of swordfish, apricot, honeysuckle, saishin, touki, pearl barley, peach, tencha and white jellyfish used in the present invention is not particularly limited, but is preferably in the range of 0.0001 to 75% by weight as a dry product. Is 0.001 to 30% by weight. If it is 0.0001% by weight or less, the effect is low, and even if it exceeds 75% by weight, the effect is hardly increased and it is not efficient. The addition method may be added in advance or during the production, and may be appropriately selected in consideration of workability.
本発明のメハジキ、アンズ、スイカズラ、サイシン、トウキ、ハトムギ、モモ、テンチャおよびシロキクラゲの抽出物はNMF産生促進効果に優れていた。また、これらの抽出物を1種又は2種以上含有する皮膚外用剤は、安全で肌の乾燥やカユミの改善効果に優れていた。 The extract of swordfish, apricot, honeysuckle, saishin, pearl oyster, pearl barley, peach, tencha, and white jellyfish of the present invention was excellent in the NMF production promoting effect. Moreover, the external preparation for skin containing one or more of these extracts was safe and excellent in the effect of improving skin dryness and itchiness.
次に本発明を詳細に説明するため、実施例として本発明に用いる抽出物の製造例、処方例及び実験例を挙げるが、本発明はこれに限定されるものではない。実施例に示す配合量は重量%を示す。 Next, in order to describe the present invention in detail, examples of production of the extract used in the present invention, formulation examples and experimental examples will be given as examples, but the present invention is not limited thereto. The compounding amount shown in the examples indicates% by weight.
製造例1 メハジキのエタノール抽出物
益母草100gに900mLの30%エタノールを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、メハジキのエタノール抽出物を7.5g得た。
Production Example 1 Mehojiki Ethanol Extract 900 ml of 30% ethanol was added to 100 g of beneficial herb, and extracted at room temperature for 7 days, followed by filtration. The filtrate was concentrated to dryness to obtain 7.5 g of Mejijiki ethanol extract. .
製造例2 アンズのエタノール抽出物
杏仁100gに900mLの30%エタノールを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、アンズのエタノール抽出物を5.3g得た。
Production Example 2 Apricot ethanol extract 900 mL of 30% ethanol was added to 100 g of apricot kernel, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness to obtain 5.3 g of apricot ethanol extract. .
製造例3 スイカズラのエタノール抽出物
金銀花100gに900mLの30%エタノールを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、スイカズラのエタノール抽出物を5.6g得た。
Production Example 3 Honeysuckle Ethanol Extract 900 g of gold and silver flowers were added with 900 mL of 30% ethanol, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness to obtain 5.6 g of honeysuckle ethanol extract. It was.
製造例4 サイシンのエタノール抽出物
細辛100gに900mLの30%エタノールを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、サイシンのエタノール抽出物を4.9g得た。
Production Example 4 Ethanol extract of saicin 900 mL of 30% ethanol was added to 100 g of fine spices, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness to obtain 4.9 g of saicin ethanol extract. It was.
製造例5 トウキのエタノール抽出物
当帰100gに900mLの30%エタノールを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、トウキのエタノール抽出物を5.5g得た。
Production Example 5 Toki Ethanol Extract 900 g of Toki was added with 900 mL of 30% ethanol, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness to obtain 5.5 g of Toki ethanol extract. It was.
製造例6 ハトムギのエタノール抽出物
ヨクイニン100gに900mLの30%エタノールを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、ハトムギのエタノール抽出物を5.7g得た。
Production Example 6 Ethanol extract of pearl barley 900 mL of 30% ethanol was added to 100 g of Yokuinin, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness to obtain 5.7 g of pearl barley ethanol extract. .
製造例7 モモのエタノール抽出物
桃仁100gに900mLの30%エタノールを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、モモのエタノール抽出物を6.5g得た。
Production Example 7 Peach ethanol extract 900 mL of 30% ethanol was added to 100 g of peach seed, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness to obtain 6.5 g of peach ethanol extract. .
製造例8 テンチャのエタノール抽出物
甜茶100gに900mLの30%エタノールを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、テンチャのエタノール抽出物を4.5g得た。
Production Example 8 Tencha ethanol extract 900 mL of 30% ethanol was added to 100 g of green tea, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness to obtain 4.5 g of tencha ethanol extract. .
製造例9 シロキクラゲのエタノール抽出物
シロキクラゲの子実体の乾燥物100gに900mLの30%エタノールを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、シロキクラゲのエタノール抽出物を3.4g得た。
Production Example 9 Ethanol extract of white jellyfish 900 mL of 30% ethanol was added to 100 g of dry matter of white jellyfish, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness to obtain ethanol extract of white jellyfish. 3.4 g was obtained.
製造例10 メハジキの熱水抽出物
益母草20gに400mLの精製水を加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してメハジキの熱水抽出物を2.2g得た。
Manufacture example 10 Hot water extract of Japanese marlin A 400 ml of purified water is added to 20 g of beneficial mother grass, extracted at 95-100 ° C. for 2 hours, filtered, and the filtrate is concentrated and freeze-dried to obtain a hot water extract of Japanese marlin. 2.2 g was obtained.
製造例11 アンズの熱水抽出物
杏仁20gに400mLの精製水を加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してアンズの熱水抽出物を2.5g得た。
Production Example 11 Hot water extract of apricot 400 mL of purified water was added to 20 g of apricot kernel, extracted at 95-100 ° C. for 2 hours, filtered, and the filtrate was concentrated and lyophilized to obtain a hot water extract of apricot. 2.5 g was obtained.
製造例12 スイカズラの熱水抽出物
金銀花20gに400mLの精製水を加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してスイカズラの熱水抽出物を2.0g得た。
Production Example 12 Hot Water Extract of Honeysuckle 400 mL of purified water was added to 20 g of gold and silver flowers, extracted at 95-100 ° C. for 2 hours, filtered, the filtrate was concentrated, freeze-dried, and hot water extract of Honeysuckle. 2.0 g was obtained.
製造例13 サイシンの熱水抽出物
細辛20gに400mLの精製水を加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してサイシンの熱水抽出物を1.5g得た。
Production Example 13 Hot water extract of saicin 400 mL of purified water was added to 20 g of fine spices, extracted at 95-100 ° C. for 2 hours, filtered, the filtrate was concentrated, freeze-dried, and hot water extract of saicin. 1.5g was obtained.
製造例14 トウキの熱水抽出物
当帰20gに400mLの精製水を加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してトウキの熱水抽出物を1.8g得た。
Production Example 14 Toki Hot Water Extract To 400 g of purified water was added 400 mL of purified water, extracted at 95-100 ° C. for 2 hours, filtered, the filtrate was concentrated, freeze-dried, and hot water extract of Toki. Of 1.8 g was obtained.
製造例15 ハトムギの熱水抽出物
ヨクイニン20gに400mLの精製水を加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してハトムギの熱水抽出物を2.3g得た。
Production Example 15 Hot water extract of pearl barley 400 mL of purified water was added to 20 g of Yokuinin, extracted at 95-100 ° C. for 2 hours, filtered, and the filtrate was concentrated and lyophilized to obtain a hot water extract of pearl barley. 2.3 g was obtained.
製造例16 モモの熱水抽出物
桃仁20gに400mLの精製水を加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してモモの熱水抽出物を1.9g得た。
Production Example 16 Hot water extract of peach 400 mL of purified water was added to 20 g of peach seed and extracted at 95-100 ° C. for 2 hours, followed by filtration. The filtrate was concentrated and freeze-dried to obtain a hot water extract of peach. 1.9 g was obtained.
製造例17 テンチャの熱水抽出物
甜茶20gに400mLの精製水を加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してテンチャの熱水抽出物を2.1g得た。
Production Example 17 Hot water extract of tencha 400 ml of purified water was added to 20 g of tea, extracted at 95-100 ° C. for 2 hours, filtered, and the filtrate was concentrated and freeze-dried to obtain hot water extract of tencha. 2.1 g was obtained.
製造例18 シロキクラゲの熱水抽出物
シロキクラゲの子実体の乾燥物20gに2Lの精製水を加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してシロキクラゲの熱水抽出物を1.5g得た。
Manufacture example 18 Hot water extract of white jellyfish 2 L of purified water was added to 20 g of dried fruit body of white jellyfish, extracted at 95-100 ° C. for 2 hours, filtered, and the filtrate was concentrated, lyophilized and dried. 1.5 g of a hot water extract was obtained.
製造例19 メハジキの1,3−ブチレングリコール水溶液抽出物
メハジキの全草の乾燥物100gに1kgの精製水及び1kgの1,3−ブチレングリコールを加え、常温で7日間抽出した後、濾過し、メハジキの1,3−ブチレングリコール水溶液抽出物を1.9kg得た。
Production Example 19 1,3-butyleneglycol aqueous solution extract of Japanese pheasant leek 1 kg of purified water and 1 kg of 1,3-butylene glycol were added to 100 g of dried whole pheasant grass, extracted at room temperature for 7 days, filtered, 1.9 kg of a 1,3-butylene glycol aqueous extract of pheasantfish was obtained.
製造例20 アンズの1,3−ブチレングリコール水溶液抽出物
杏仁100gに1kgの精製水及び1kgの1,3−ブチレングリコールを加え、常温で7日間抽出した後、濾過し、アンズの1,3−ブチレングリコール水溶液抽出物を1.9kg得た。
Production Example 20 Apricot 1,3-butylene glycol aqueous extract 1 kg of purified water and 1 kg of 1,3-butylene glycol were added to 100 g of apricot kernel, extracted at room temperature for 7 days, filtered, and apricot 1,3-butylene glycol. 1.9 kg of aqueous butylene glycol extract was obtained.
製造例21 スイカズラの1,3−ブチレングリコール水溶液抽出物
忍冬100gに1kgの精製水及び1kgの1,3−ブチレングリコールを加え、常温で7日間抽出した後、濾過し、スイカズラの1,3−ブチレングリコール水溶液抽出物を1.9kg得た。
Production Example 21 1,3-butylene glycol aqueous extract of honeysuckle Add 1 kg of purified water and 1 kg of 1,3-butyleneglycol to 100 g of Shinobifu, extract for 7 days at room temperature, filter, 1.9 kg of aqueous butylene glycol extract was obtained.
製造例22 サイシンの1,3−ブチレングリコール水溶液抽出物
細辛100gに1kgの精製水及び1kgの1,3−ブチレングリコールを加え、常温で7日間抽出した後、濾過し、サイシンの1,3−ブチレングリコール水溶液抽出物を1.9kg得た。
Production Example 22 1,3-Butyleneglycol aqueous solution extract of saicin 1 kg of purified water and 1 kg of 1,3-butyleneglycol were added to 100 g of fine spicy, extracted at room temperature for 7 days, filtered, and filtered. -1.9 kg of butylene glycol aqueous solution extract was obtained.
製造例23 トウキの1,3−ブチレングリコール水溶液抽出物
当帰100gに1kgの精製水及び1kgの1,3−ブチレングリコールを加え、常温で7日間抽出した後、濾過し、トウキの1,3−ブチレングリコール水溶液抽出物を1.9kg得た。
Production Example 23 1,3-butylene glycol aqueous extract of touki 1 kg of purified water and 1 kg of 1,3-butylene glycol were added to 100 g of Toki, extracted at room temperature for 7 days, filtered, and filtered. -1.9 kg of butylene glycol aqueous solution extract was obtained.
製造例24 ハトムギの1,3−ブチレングリコール水溶液抽出物
ヨクイニン100gに1kgの精製水及び1kgの1,3−ブチレングリコールを加え、常温で7日間抽出した後、濾過し、ハトムギの1,3−ブチレングリコール水溶液抽出物を1.9kg得た。
Production Example 24 1,3-butylene glycol aqueous extract of pearl barley 1 kg of purified water and 1 kg of 1,3-butylene glycol were added to 100 g of yokuinin, extracted at room temperature for 7 days, filtered, and filtered. 1.9 kg of aqueous butylene glycol extract was obtained.
製造例25 モモの1,3−ブチレングリコール水溶液抽出物
桃仁100gに1kgの精製水及び1kgの1,3−ブチレングリコールを加え、常温で7日間抽出した後、濾過し、モモの1,3−ブチレングリコール水溶液抽出物を1.9kg得た。
Production Example 25 Extract of 1,3-butylene glycol aqueous solution of peach 1 kg of purified water and 1 kg of 1,3-butylene glycol were added to 100 g of peach seed, extracted at room temperature for 7 days, filtered, filtered, 1.9 kg of aqueous butylene glycol extract was obtained.
製造例26 テンチャの1,3−ブチレングリコール水溶液抽出物
甜茶100gに1kgの精製水及び1kgの1,3−ブチレングリコールを加え、常温で7日間抽出した後、濾過し、テンチャの1,3−ブチレングリコール水溶液抽出物を1.9kg得た。
Production Example 26 1,3-Butylene Glycol Aqueous Extract of Tencha 1 kg of purified water and 1 kg of 1,3-butylene glycol were added to 100 g of green tea, extracted for 7 days at room temperature, filtered, and filtered. 1.9 kg of aqueous butylene glycol extract was obtained.
製造例27 シロキクラゲの1,3−ブチレングリコール水溶液抽出物
シロキクラゲの子実体の乾燥物100gに1kgの精製水及び1kgの1,3−ブチレングリコールを加え、常温で7日間抽出した後、濾過し、シロキクラゲの1,3−ブチレングリコール水溶液抽出物を1.9kg得た。
Production Example 27 1,3-butylene glycol aqueous extract of white jellyfish 1 kg of purified water and 1 kg of 1,3-butylene glycol were added to 100 g of dried fruit body of white jellyfish, extracted at room temperature for 7 days, filtered, 1.9 kg of a 1,3-butylene glycol aqueous extract of white jellyfish was obtained.
次に、本発明に係る実施例の処方を示す。 Next, the prescription of the Example which concerns on this invention is shown.
処方例1 クリーム1
処方 配合量(重量%)
1.メハジキのエタノール抽出物(製造例1) 0.5
2.スクワラン 5.5
3.オリーブ油 3.0
4.ステアリン酸 2.0
5.ミツロウ 2.0
6.ミリスチン酸オクチルドデシル 3.5
7.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
8.ベヘニルアルコール 1.5
9.モノステアリン酸グリセリン 2.5
10.香料 0.1
11.1,3−ブチレングリコール 8.5
12.パラオキシ安息香酸エチル 0.05
13.パラオキシ安息香酸メチル 0.2
14.精製水 67.65
[製造方法]成分2〜9を加熱して混合し、70℃に保ち油相とする。成分1及び11〜14を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら冷却し、45℃で成分10を加え、更に30℃まで冷却して製品とする。
Formulation Example 1 Cream 1
Formulation amount (% by weight)
1. Shrimp ethanol extract (Production Example 1) 0.5
2. Squalane 5.5
3. Olive oil 3.0
4). Stearic acid 2.0
5). Beeswax 2.0
6). Octyldodecyl myristate 3.5
7). Polyoxyethylene cetyl ether (20E.O.) 3.0
8). Behenyl alcohol 1.5
9. Glycerol monostearate2.5
10. Fragrance 0.1
11.1,3-butylene glycol 8.5
12 Ethyl paraoxybenzoate 0.05
13. Methyl paraoxybenzoate 0.2
14 Purified water 67.65
[Production Method] Components 2 to 9 are heated and mixed, and kept at 70 ° C. to obtain an oil phase. Ingredients 1 and 11 to 14 are dissolved by heating and mixed, and kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled while stirring. The component 10 is added at 45 ° C., and further cooled to 30 ° C. to obtain a product.
処方例2 クリーム2
処方例1において、メハジキのエタノール抽出物をアンズのエタノール抽出物(製造例2)に置き換えたものをクリーム2とした。
Formulation Example 2 Cream 2
In Formulation Example 1, cream 2 was obtained by replacing the peafish ethanol extract with apricot ethanol extract (Production Example 2).
処方例3 クリーム3
処方例1において、メハジキのエタノール抽出物をスイカズラのエタノール抽出物(製造例3)に置き換えたものをクリーム3とした。
Formulation Example 3 Cream 3
In Formulation Example 1, cream 3 was obtained by substituting the Japanese extract of honeyfish with an extract of honeysuckle (Production Example 3).
処方例4 クリーム4
処方例1において、メハジキのエタノール抽出物をサイシンのエタノール抽出物(製造例4)に置き換えたものをクリーム4とした。
Formulation Example 4 Cream 4
In Formulation Example 1, cream 4 was obtained by replacing the ethanol extract of swordfish with the ethanol extract of Saicin (Production Example 4).
処方例5 クリーム5
処方例1において、メハジキのエタノール抽出物をトウキのエタノール抽出物(製造例5)に置き換えたものをクリーム5とした。
Formulation Example 5 Cream 5
In Formulation Example 1, cream 5 was obtained by substituting the ethanol extract of Mejijiki with the ethanol extract of Toki (Production Example 5).
処方例6 クリーム6
処方例1において、メハジキのエタノール抽出物をハトムギのエタノール抽出物(製造例6)に置き換えたものをクリーム6とした。
Formulation Example 6 Cream 6
In Formulation Example 1, cream 6 was obtained by replacing the ethanol extract of swordfish with the ethanol extract of pearl barley (Production Example 6).
処方例7 クリーム7
処方例1において、メハジキのエタノール抽出物をモモのエタノール抽出物(製造例7)に置き換えたものをクリーム7とした。
Formulation Example 7 Cream 7
In Formulation Example 1, cream 7 was obtained by replacing the ethanol extract of eelfish with an extract of peach ethanol (Production Example 7).
処方例8 クリーム8
処方例1において、メハジキのエタノール抽出物をテンチャのエタノール抽出物(製造例8)に置き換えたものをクリーム8とした。
Formulation Example 8 Cream 8
In Formulation Example 1, cream 8 was obtained by replacing the ethanol extract of Japanese cypress with the ethanol extract of tencha (Production Example 8).
処方例9 クリーム9
処方例1において、メハジキのエタノール抽出物をシロキクラゲのエタノール抽出物(製造例9)に置き換えたものをクリーム9とした。
Formulation Example 9 Cream 9
In Formulation Example 1, cream 9 was obtained by replacing the ethanol extract of swordfish with an ethanol extract of white jellyfish (Production Example 9).
比較例1 従来のクリーム
処方例1において、メハジキのエタノール抽出物を精製水に置き換えたものを従来のクリームとした。
Comparative Example 1 Conventional Cream In Formulation Example 1, a conventional cream was obtained by substituting an ethanol extract of a swordfish with purified water.
処方例10 化粧水
処方 配合量(重量%)
1.メハジキの1,3−ブチレン
グリコール水溶液抽出物(製造例19) 0.1
2.1,3−ブチレングリコール 8.0
3.グリセリン 2.0
4.キサンタンガム 0.02
5.クエン酸 0.01
6.クエン酸ナトリウム 0.1
7.エタノール 5.0
8.パラオキシ安息香酸メチル 0.1
9.ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.1
10.香料 0.1
11.精製水 84.47
[製造方法]成分1〜6及び11と、成分7〜10をそれぞれ均一に溶解し、両者を混合し濾過して製品とする。
Formulation Example 10 Lotion Formulation Amount (% by weight)
1. 1,3-butylene glycol aqueous solution extract of mehajiki (Production Example 19) 0.1
2. 1,3-butylene glycol 8.0
3. Glycerin 2.0
4). Xanthan gum 0.02
5). Citric acid 0.01
6). Sodium citrate 0.1
7). Ethanol 5.0
8). Methyl paraoxybenzoate 0.1
9. Polyoxyethylene hydrogenated castor oil (40E.O.) 0.1
10. Fragrance 0.1
11. Purified water 84.47
[Production method] Components 1 to 6 and 11 and components 7 to 10 are uniformly dissolved, and both are mixed and filtered to obtain a product.
処方例11 乳液
処方 配合量(重量%)
1.アンズの熱水抽出物(製造例11) 0.05
2.スクワラン 5.0
3.オリーブ油 5.0
4.ホホバ油 5.0
5.セタノール 1.5
6.モノステアリン酸グリセリン 2.0
7.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
8.ポリオキシエチレンソルビタンモノオレエート 2.0
9.香料 0.1
10.プロピレングリコール 1.0
11.グリセリン 2.0
12.パラオキシ安息香酸メチル 0.2
13.精製水 73.15
[製造方法]成分2〜8を加熱溶解して混合し、70℃に保ち油相とする。成分1及び10〜13を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら冷却し、45℃で成分9を加え、更に30℃まで冷却して製品とする。
Formulation Example 11 Emulsion Formulation Formulation (wt%)
1. Apricot hot water extract (Production Example 11) 0.05
2. Squalane 5.0
3. Olive oil 5.0
4). Jojoba oil 5.0
5). Cetanol 1.5
6). Glycerol monostearate 2.0
7). Polyoxyethylene cetyl ether (20E.O.) 3.0
8). Polyoxyethylene sorbitan monooleate 2.0
9. Fragrance 0.1
10. Propylene glycol 1.0
11. Glycerin 2.0
12 Methyl paraoxybenzoate 0.2
13. Purified water 73.15
[Manufacturing method] Components 2 to 8 are dissolved by heating and mixed, and kept at 70 ° C to obtain an oil phase. Ingredients 1 and 10-13 are dissolved by heating and mixed, and kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled while stirring. The component 9 is added at 45 ° C., and further cooled to 30 ° C. to obtain a product.
処方例12 軟膏
処方 配合量(重量%)
1.スイカズラの1,3−ブチレン
グリコール水溶液抽出物(製造例21) 1.0
2.ポリオキシエチレンセチルエーテル(30E.O.) 2.0
3.モノステアリン酸グリセリン 10.0
4.流動パラフィン 5.0
5.セタノール 6.0
6.パラオキシ安息香酸メチル 0.1
7.プロピレングリコール 10.0
8.精製水 65.9
[製造方法]成分2〜5を加熱溶解して混合し、70℃に保ち油相とする。成分1及び6〜8を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら30℃まで冷却して製品とする。
Formulation Example 12 Ointment Formulation Amount (% by weight)
1. Honeysuckle 1,3-butylene
Glycol aqueous solution extract (Production Example 21) 1.0
2. Polyoxyethylene cetyl ether (30E.O.) 2.0
3. Glycerol monostearate 10.0
4). Liquid paraffin 5.0
5). Cetanol 6.0
6). Methyl paraoxybenzoate 0.1
7). Propylene glycol 10.0
8). Purified water 65.9
[Manufacturing method] Components 2 to 5 are dissolved by heating and mixed, and kept at 70 ° C to obtain an oil phase. Ingredients 1 and 6 to 8 are dissolved by heating and mixed, and kept at 75 ° C. to obtain an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled to 30 ° C. with stirring to obtain a product.
処方例13 ファンデーション
処方 配合量(重量%)
1.サイシンの1,3−ブチレン
グリコール水溶液抽出物(製造例22) 1.0
2.ステアリン酸 2.4
3.ポリオキシエチレンソルビタンモノステアレート 1.0
(20E.O.)
4.ポリオキシエチレンセチルエーテル(20E.O.) 2.0
5.セタノール 1.0
6.液状ラノリン 2.0
7.流動パラフィン 3.0
8.ミリスチン酸イソプロピル 6.5
9.パラオキシ安息香酸ブチル 0.1
10.カルボキシメチルセルロースナトリウム 0.1
11.ベントナイト 0.5
12.プロピレングリコール 4.0
13.トリエタノールアミン 1.1
14.パラオキシ安息香酸メチル 0.2
15.二酸化チタン 8.0
16.タルク 4.0
17.ベンガラ 1.0
18.黄酸化鉄 2.0
19.香料 0.1
20.精製水 60.0
[製造方法]成分2〜9を加熱溶解し、80℃に保ち油相とする。成分20に成分10をよく膨潤させ、続いて、成分1及び11〜14を加えて均一に混合する。これに粉砕機で粉砕混合した成分15〜18を加え、ホモミキサーで撹拌し75℃に保ち水相とする。この水相に油相をかき混ぜながら加え、冷却し、45℃で成分19を加え、かき混ぜながら30℃まで冷却して製品とする。
Formulation Example 13 Foundation Formulation Amount (% by weight)
1. Saisin 1,3-butylene
Glycol aqueous solution extract (Production Example 22) 1.0
2. Stearic acid 2.4
3. Polyoxyethylene sorbitan monostearate 1.0
(20 EO)
4). Polyoxyethylene cetyl ether (20E.O.) 2.0
5). Cetanol 1.0
6). Liquid lanolin 2.0
7). Liquid paraffin 3.0
8). Isopropyl myristate 6.5
9. Butyl paraoxybenzoate 0.1
10. Sodium carboxymethylcellulose 0.1
11. Bentonite 0.5
12 Propylene glycol 4.0
13. Triethanolamine 1.1
14 Methyl paraoxybenzoate 0.2
15. Titanium dioxide 8.0
16. Talc 4.0
17. Bengala 1.0
18. Yellow iron oxide 2.0
19. Fragrance 0.1
20. Purified water 60.0
[Manufacturing method] Components 2 to 9 are heated and dissolved and kept at 80 ° C to obtain an oil phase. Swell component 10 well with component 20, then add components 1 and 11-14 and mix uniformly. To this, components 15 to 18 pulverized and mixed with a pulverizer are added, and the mixture is stirred with a homomixer and kept at 75 ° C. to obtain an aqueous phase. The oily phase is added to the aqueous phase with stirring, cooled, and component 19 is added at 45 ° C, and cooled to 30 ° C with stirring to give a product.
処方例14 浴用剤
処方 配合量(重量%)
1.トウキの熱水抽出物(製造例14) 5.0
2.炭酸水素ナトリウム 50.0
3.黄色202号(1) 0.05
4.香料 0.25
5.無水硫酸ナトリウム 44.7
[製造方法]成分1〜5を均一に混合し製品とする。
Formulation Example 14 Bath preparation formulation Formulation amount (% by weight)
1. Toki hot water extract (Production Example 14) 5.0
2. Sodium bicarbonate 50.0
3. Yellow No. 202 (1) 0.05
4). Fragrance 0.25
5). Anhydrous sodium sulfate 44.7
[Production method] Components 1 to 5 are uniformly mixed to obtain a product.
処方例15 錠菓
処方 配合量(重量%)
1.ハトムギの熱水抽出物(製造例15) 2.0
2.乾燥コーンスターチ 50.0
3.エリスリトール 40.0
4.クエン酸 5.0
5.ショ糖脂肪酸エステル 3.0
6.香料 適量
7.水 適量
[製造方法]成分1〜4及び7を混合し、顆粒成形する。成形した顆粒に成分5及び6を加えて打錠する。1粒1.0gとする。
Formulation Example 15 Tablet Confectionery Formulation Amount (% by weight)
1. Hot water extract of pearl barley (Production Example 15) 2.0
2. Dried corn starch 50.0
3. Erythritol 40.0
4). Citric acid 5.0
5). Sucrose fatty acid ester 3.0
6). Perfume appropriate amount 7. Water Appropriate amount [Production method] Components 1 to 4 and 7 are mixed and granulated. Ingredients 5 and 6 are added to the formed granules and compressed. One tablet is 1.0 g.
処方例16 飲料
処方 配合量(重量%)
1.モモの熱水抽出物(製造例16) 1.0
2.ステビア 0.05
3.リンゴ酸 5.0
4.香料 0.1
5.水にて全量を100とする
[製造方法]成分2及び3を少量の水に溶解する。次いで、成分1及び4、5を加えて混合する。
Formulation Example 16 Beverage Formulation Amount (% by weight)
1. Peach hot water extract (Production Example 16) 1.0
2. Stevia 0.05
3. Malic acid 5.0
4). Fragrance 0.1
5). [Production method] Components 2 and 3 are dissolved in a small amount of water. Components 1 and 4, 5 are then added and mixed.
処方例17 錠剤
処方 配合量(重量%)
1.シロキクラゲの熱水抽出物(製造例18) 10.0
2.トウモロコシデンプン 10.0
3.精製白糖 20.0
4.カルボキシメチルセルロース 10.0
5.微結晶セルロース 35.0
6.ポリビニルピロリドン 5.0
7.タルク 10.0
[製造方法]成分1〜5を混合し、次いで成分6の水溶液を結合剤として加えて常法により顆粒化した。これに滑沢剤として成分7を加えて配合した後、1錠100mgの錠剤に打錠した。
Formulation Example 17 Tablet formulation Formulation amount (% by weight)
1. White water jellyfish extract (Production Example 18) 10.0
2. Corn starch 10.0
3. Purified white sugar 20.0
4). Carboxymethylcellulose 10.0
5). Microcrystalline cellulose 35.0
6). Polyvinylpyrrolidone 5.0
7). Talc 10.0
[Production Method] Components 1 to 5 were mixed, and then an aqueous solution of Component 6 was added as a binder and granulated by a conventional method. This was mixed with ingredient 7 as a lubricant and then tableted into 100 mg tablets.
処方例18 散剤
処方 配合量(重量%)
1.テンチャの熱水抽出物(製造例17) 10.0
2.トウモロコシデンプン 40.0
3.微結晶セルロース 50.0
[製造方法]上記成分を混合し、常法により散剤とした。
Formulation Example 18 Powder Formulation Amount (% by weight)
1. Tencha hot water extract (Production Example 17) 10.0
2. Corn starch 40.0
3. Microcrystalline cellulose 50.0
[Production method] The above components were mixed and powdered by a conventional method.
処方例19 注射剤
処方 配合量(重量%)
1.メハジキの熱水抽出物(製造例10) 1.0
2.ポリオキシエチレン(60)硬化ヒマシ油 3.7
3.ゴマ油 0.2
4.塩化ナトリウム 0.9
5.プロピレングリコール 4.0
6.リン酸緩衝液(0.1M、pH6.0) 10.0
7.蒸留水 80.2
[製造方法]成分2、3及び成分5の半量を混合して約80℃で加温溶解し、これに成分1と4〜6を予め溶解した成分7を約80℃に加温して加え全量を1000mLの水溶液とした。この水溶液を1mLのアンプルに分注して熔閉した後、加熱滅菌した。
Formulation Example 19 Injection formulation Formulation amount (% by weight)
1. Hot water extract of Japanese pheasant (Production Example 10) 1.0
2. Polyoxyethylene (60) hydrogenated castor oil 3.7
3. Sesame oil 0.2
4). Sodium chloride 0.9
5). Propylene glycol 4.0
6). Phosphate buffer (0.1 M, pH 6.0) 10.0
7). Distilled water 80.2
[Production method] Components 2, 3 and half of component 5 are mixed and dissolved by heating at about 80 ° C. To this, component 7 in which components 1 and 4 to 6 are previously dissolved is heated to about 80 ° C and added. The total amount was 1000 mL of an aqueous solution. This aqueous solution was dispensed into 1 mL ampules, melted and then sterilized by heating.
次に、本発明の効果を詳細に説明するため、実験例をあげる。 Next, experimental examples will be given to explain the effects of the present invention in detail.
実験例1 ケラチノサイトのNMF産生促進試験
培養ケラチノサイトのNMF産生の指標となるプロフィラグリンmRNA発現量を下記の条件にて測定した。
Experimental Example 1 NMF Production Promotion Test of Keratinocytes Profilagrin mRNA expression level as an index of NMF production of cultured keratinocytes was measured under the following conditions.
プロフィラグリンmRNA発現に及ぼす影響の評価法
マウスケラチノサイト由来Pam212細胞を10% FCSを含むEagle’s MEM培地にて37℃、5%CO2条件下で培養した。コンフルエントな状態なったところで0.01mg/ml濃度の試料を添加したEagle’s MEM培地にてさらに24時間培養した後、総RNAの抽出を行った(n=3)。総RNAの抽出にはISOGEN(ニッポンジーン)を用いた。Pam212細胞から抽出した総RNAを基にRT−PCR法によりプロフィラグリンmRNA発現量の測定を行った。RT−PCR法にはTaKaRa RNA PCR Kit (AMV) Ver.2.1を用い、プロフィラグリン用のprimerとしては5’GAATCCATATTTACAGCAAAGCACCTTG 3’および5’GGTATGTCCAATGTGATTGCACGATTG3’を用いた。また、内部標準としてはGAPDHを用いた。その他の操作は定められた方法にしたがい、PCR反応液をアガロースゲル電気泳動に供し、プロフィラグリンおよびGAPDHのmRNA発現をバンドとして確認した。これらのバンドをポラロイドカメラにて撮影してデンシトメーターを用いて定量化し、プロフィラグリンmRNAの発現量を内部標準であるGAPDH mRNA発現量に対する割合として求めた。
NMF産生率(%)=B/A×100
A:抽出物未添加の場合のプロフィラグリン/GAPDH mRNA発現量
B:抽出物添加の場合のプロフィラグリン/GAPDH mRNA発現量
Evaluation Method of Effects on Profilaggrin mRNA Expression Mouse keratinocyte-derived Pam212 cells were cultured in Eagle's MEM medium containing 10% FCS under conditions of 37 ° C. and 5% CO 2 . After becoming confluent, the cells were further cultured for 24 hours in Eagle's MEM medium supplemented with a 0.01 mg / ml sample, and then total RNA was extracted (n = 3). ISOGEN (Nippon Gene) was used for extraction of total RNA. Based on the total RNA extracted from Pam212 cells, the profilagrin mRNA expression level was measured by RT-PCR. The RT-PCR method includes TaKaRa RNA PCR Kit (AMV) Ver. 2.1 and 5′GAATCCATTTTACAGCAAAGCACCTG 3 ′ and 5 ′ GGTATGTCCAAATGTATTGCACGATGTG3 ′ were used as the primers for profilaggrin. GAPDH was used as an internal standard. Other operations were carried out in accordance with a predetermined method, and the PCR reaction solution was subjected to agarose gel electrophoresis, and profilagrin and GAPDH mRNA expression was confirmed as a band. These bands were photographed with a polaroid camera and quantified using a densitometer, and the expression level of profilagrin mRNA was determined as a ratio with respect to the expression level of GAPDH mRNA as an internal standard.
NMF production rate (%) = B / A × 100
A: Profilagrin / GAPDH mRNA expression level when no extract is added B: Profilagrin / GAPDH mRNA expression level when an extract is added
これらの試験結果を表1に示した。その結果、メハジキ、アンズ、スイカズラ、サイシン、トウキ、ハトムギ、モモ、テンチャおよびシロキクラゲの抽出物には優れたNMF産生促進作用が認められた。また、製造例10〜27の抽出物の試験を行ったところ、いずれも優れたNMF産生促進作用を示した。 The test results are shown in Table 1. As a result, excellent NMF production-promoting action was observed in the extracts of swordfish, apricot, honeysuckle, saicin, touki, pearl barley, peach, tencha, and white jellyfish. Moreover, when the extract of the manufacture examples 10-27 was tested, all showed the outstanding NMF production promotion effect | action.
実験例2 使用試験
処方例1〜9のクリーム及び比較例1の従来のクリームを用いて、各々肌の乾燥やカユミに悩む女性30人(30〜45才)を対象に2ヶ月間の使用試験を行った。使用後、肌の乾燥およびカユミの改善効果についてのアンケート調査を行った。アンケートの評価基準は、有効なものを「優」、やや有効なものを「良」、わずかに有効なものを「可」、無効なものを「不可」として評価した。
Experimental example 2 Use test Two months use test for 30 women (30-45 years old) suffering from dryness of skin and Kayumi using the creams of prescription examples 1-9 and the conventional cream of comparative example 1, respectively. Went. After use, a questionnaire survey was conducted on the effects of dry skin and improvement of Kayumi. The evaluation criteria of the questionnaire were evaluated as “excellent” for valid, “good” for slightly effective, “good” for slightly effective, and “impossible” for invalid.
これらの結果を表2に示した。処方例1〜9のNMF産生促進剤を含む皮膚外用剤は優れた肌の乾燥やカユミの改善効果を示した。なお、試験期間中皮膚トラブルは一人もなく、安全性においても問題なかった。 These results are shown in Table 2. The external preparation for skin containing the NMF production promoter of Formulation Examples 1 to 9 showed excellent skin dryness and amelioration effects on Kayumi. During the test period, there was no skin problem and there was no problem with safety.
処方例10〜18の化粧水、乳液、軟膏、ファンデーション、浴用剤、錠菓、飲料、錠剤および散剤の使用試験を行ったところ、いずれも安全で優れた肌の乾燥やカユミの改善効果を示した。 When the usage tests of lotions, emulsions, ointments, foundations, bath preparations, tablet confectionery, beverages, tablets and powders of Formulation Examples 10 to 18 were conducted, all showed safe and excellent skin dryness and amelioration effects It was.
本発明の活用例として、食品、化粧品、医薬部外品または医薬品のいずれにも用いることができる。その剤型としては、錠菓、飲料、化粧水、クリーム、乳液、ゲル剤、エアゾール剤、軟膏、パップ剤、ペースト剤、プラスター剤、エッセンス、パック、洗浄剤、浴用剤、ファンデーション、打粉、口紅、散剤、丸剤、錠剤、注射剤、坐剤、乳剤、カプセル剤、顆粒剤、液剤(チンキ剤、流エキス剤、酒精剤、懸濁剤、リモナーデ剤などを含む)等が挙げられ、表皮細胞におけるNMFの産生促進により角質層の保湿機能を高め、肌の乾燥やカユミの改善効果が得られる。
As an application example of the present invention, it can be used for any of foods, cosmetics, quasi drugs, and pharmaceuticals. The dosage forms include tablet confectionery, beverages, lotions, creams, emulsions, gels, aerosols, ointments, poultices, pastes, plasters, essences, packs, cleaning agents, bath preparations, foundations, powders, lipsticks. , Powders, pills, tablets, injections, suppositories, emulsions, capsules, granules, liquids (including tinctures, fluid extracts, spirits, suspensions, limonades, etc.) By promoting NMF production in cells, the moisturizing function of the stratum corneum is enhanced, and the effect of improving skin dryness and kayumi is obtained.
Claims (4)
A skin external preparation for improving oysters, characterized by containing one or more extracts selected from mejijiki, apricot, honeysuckle, saishin, touki, pearl barley, peach, tencha and white jellyfish.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004317529A JP2006124350A (en) | 2004-11-01 | 2004-11-01 | Nmf production promoter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004317529A JP2006124350A (en) | 2004-11-01 | 2004-11-01 | Nmf production promoter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2006124350A true JP2006124350A (en) | 2006-05-18 |
Family
ID=36719421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004317529A Pending JP2006124350A (en) | 2004-11-01 | 2004-11-01 | Nmf production promoter |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2006124350A (en) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008007412A (en) * | 2006-06-27 | 2008-01-17 | Maruzen Pharmaceut Co Ltd | Involucrin production promoter and epidermal keratinization-normalizing agent |
| JP2008100981A (en) * | 2006-10-17 | 2008-05-01 | Engelhard Lyon Sas | Use of substances to protect FGF-2 or FGF-β growth factors |
| JP2008303203A (en) * | 2007-05-08 | 2008-12-18 | Naris Cosmetics Co Ltd | Cosmetics |
| JP2009040694A (en) * | 2007-08-07 | 2009-02-26 | Kao Corp | Skin cosmetics |
| JP2009256244A (en) * | 2008-04-17 | 2009-11-05 | Maruzen Pharmaceut Co Ltd | Claudin production promoter, occludin production promoter and skin barrier function-improving agent |
| JP2009269900A (en) * | 2008-04-07 | 2009-11-19 | Kao Corp | Accelerator for forming tight junction |
| JP2010070497A (en) * | 2008-09-18 | 2010-04-02 | Kao Corp | Ceramide production promoter, moisturizer and skin care external preparation |
| JP2010195740A (en) * | 2009-02-27 | 2010-09-09 | Kose Corp | Ceramide production-promoter, external preparation for skin, and cosmetic |
| WO2011093418A1 (en) * | 2010-01-27 | 2011-08-04 | 株式会社 資生堂 | Agent for promoting differentiation of adipocyte precursor cells |
| JP2012006876A (en) * | 2010-06-25 | 2012-01-12 | Sansho Seiyaku Co Ltd | Method for producing stable lonicera japonica extract liquid |
| JP2012219047A (en) * | 2011-04-06 | 2012-11-12 | Maruzen Pharmaceut Co Ltd | PROFILAGGRIN mRNA EXPRESSION PROMOTER |
| JP2014074074A (en) * | 2008-08-18 | 2014-04-24 | Zhongshan Hospital of Fudan University | Ceramide production accelerant |
| JP2014091721A (en) * | 2012-11-05 | 2014-05-19 | Kao Corp | Ceramide production promoter |
| JP2014105167A (en) * | 2012-11-26 | 2014-06-09 | Kyoei Kagaku Kogyo Kk | Cosmetic |
| JP2014224825A (en) * | 2008-11-11 | 2014-12-04 | 株式会社アモーレパシフィックAmorepacific Corporation | Method of quantifying skin change resulting from six exogenous pathogenic factors, and method of screening skin improvement material using the same |
| CN107468836A (en) * | 2017-09-13 | 2017-12-15 | 云南卡瓦格博生物科技有限公司 | Treat the Tibetan medicine and its processing method of gynaecological imflammation |
| KR101862039B1 (en) * | 2017-01-10 | 2018-05-29 | 주식회사 아미코스메틱 | A cosmetic composition containing spicule powder and natural complex extract stabilized in nanoliposome |
| JP2018083794A (en) * | 2016-11-25 | 2018-05-31 | 株式会社コーセー | Epithelial cell activator |
| KR20190014477A (en) * | 2017-08-02 | 2019-02-12 | 주식회사 인투바이오 | Tremella fuciformis extraxt, preparation method thereof and Use the same |
| JP2020094000A (en) * | 2018-12-13 | 2020-06-18 | 株式会社ノエビア | Skin external preparation |
| JP2023108695A (en) * | 2022-01-26 | 2023-08-07 | 株式会社テクノーブル | Skin topical agent |
-
2004
- 2004-11-01 JP JP2004317529A patent/JP2006124350A/en active Pending
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008007412A (en) * | 2006-06-27 | 2008-01-17 | Maruzen Pharmaceut Co Ltd | Involucrin production promoter and epidermal keratinization-normalizing agent |
| JP2008100981A (en) * | 2006-10-17 | 2008-05-01 | Engelhard Lyon Sas | Use of substances to protect FGF-2 or FGF-β growth factors |
| JP2008303203A (en) * | 2007-05-08 | 2008-12-18 | Naris Cosmetics Co Ltd | Cosmetics |
| JP2009040694A (en) * | 2007-08-07 | 2009-02-26 | Kao Corp | Skin cosmetics |
| JP2009269900A (en) * | 2008-04-07 | 2009-11-19 | Kao Corp | Accelerator for forming tight junction |
| JP2009256244A (en) * | 2008-04-17 | 2009-11-05 | Maruzen Pharmaceut Co Ltd | Claudin production promoter, occludin production promoter and skin barrier function-improving agent |
| JP2014074074A (en) * | 2008-08-18 | 2014-04-24 | Zhongshan Hospital of Fudan University | Ceramide production accelerant |
| US10610561B2 (en) | 2008-08-18 | 2020-04-07 | Zhongshan Hospital of Fudan University | Ceramide production-accelerating agent |
| JP2010070497A (en) * | 2008-09-18 | 2010-04-02 | Kao Corp | Ceramide production promoter, moisturizer and skin care external preparation |
| JP2014224825A (en) * | 2008-11-11 | 2014-12-04 | 株式会社アモーレパシフィックAmorepacific Corporation | Method of quantifying skin change resulting from six exogenous pathogenic factors, and method of screening skin improvement material using the same |
| JP2010195740A (en) * | 2009-02-27 | 2010-09-09 | Kose Corp | Ceramide production-promoter, external preparation for skin, and cosmetic |
| WO2011093418A1 (en) * | 2010-01-27 | 2011-08-04 | 株式会社 資生堂 | Agent for promoting differentiation of adipocyte precursor cells |
| JP2012006876A (en) * | 2010-06-25 | 2012-01-12 | Sansho Seiyaku Co Ltd | Method for producing stable lonicera japonica extract liquid |
| JP2012219047A (en) * | 2011-04-06 | 2012-11-12 | Maruzen Pharmaceut Co Ltd | PROFILAGGRIN mRNA EXPRESSION PROMOTER |
| JP2014091721A (en) * | 2012-11-05 | 2014-05-19 | Kao Corp | Ceramide production promoter |
| JP2014105167A (en) * | 2012-11-26 | 2014-06-09 | Kyoei Kagaku Kogyo Kk | Cosmetic |
| JP2018083794A (en) * | 2016-11-25 | 2018-05-31 | 株式会社コーセー | Epithelial cell activator |
| KR101862039B1 (en) * | 2017-01-10 | 2018-05-29 | 주식회사 아미코스메틱 | A cosmetic composition containing spicule powder and natural complex extract stabilized in nanoliposome |
| KR20190014477A (en) * | 2017-08-02 | 2019-02-12 | 주식회사 인투바이오 | Tremella fuciformis extraxt, preparation method thereof and Use the same |
| KR102085559B1 (en) * | 2017-08-02 | 2020-03-06 | 주식회사 인투바이오 | Tremella fuciformis extraxt, preparation method thereof and Use the same |
| CN107468836A (en) * | 2017-09-13 | 2017-12-15 | 云南卡瓦格博生物科技有限公司 | Treat the Tibetan medicine and its processing method of gynaecological imflammation |
| JP2020094000A (en) * | 2018-12-13 | 2020-06-18 | 株式会社ノエビア | Skin external preparation |
| JP2022173364A (en) * | 2018-12-13 | 2022-11-18 | 株式会社ノエビア | Skin external preparation |
| JP2023108695A (en) * | 2022-01-26 | 2023-08-07 | 株式会社テクノーブル | Skin topical agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1242103B1 (en) | Extracts derived from pueraria mirifica and extraction thereof | |
| JP2006124350A (en) | Nmf production promoter | |
| JP2006111560A (en) | Ceramide synthesis promoter | |
| JP2006111545A (en) | Glutathione reductase activity-enhancing agent | |
| JPH10120583A (en) | Antiallergic agent, chemical mediator liberation suppressant and antiallergic cosmetic, medicine and food comprising the sam | |
| JP2004067590A (en) | Female sex hormone production promoter and skin preparation for external use containing the same | |
| JP6895860B2 (en) | Slimming foods and topical compositions | |
| JP2016160198A (en) | Kaempferia parviflora-containing compositions | |
| JP5101769B2 (en) | Antibiotic antioxidant or preventive agent | |
| KR101347910B1 (en) | a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented | |
| JP4460420B2 (en) | Collagen production promoter | |
| JP6765090B2 (en) | Black ginger-containing composition | |
| JP2005023021A (en) | Elastase inhibitor | |
| KR102292114B1 (en) | Composition for Improving Skin Conditions Having Moisturizing, Anti-Inflammatory Caused by Fine Dust and Pore Shrinkage Property Comprising Plant Complex Extracts as Active Ingredient | |
| JP4421847B2 (en) | Lipolysis accelerator | |
| JP5313524B2 (en) | Anti-inflammatory agent and anti-inflammatory skin external preparation | |
| JP5690149B2 (en) | External preparation or internal preparation | |
| JP6908265B2 (en) | Apoptosis inhibitor | |
| JP2005194239A (en) | Ceramide synthesis promotor and skin care preparation for external use | |
| JP2005139141A (en) | Collagen synthesis promoter and external preparation for the skin | |
| JP6281761B2 (en) | External preparation or internal preparation containing Hidakami Sebaya extract | |
| JP5850488B2 (en) | Acne improver | |
| JP2002029996A (en) | Proteasome activation accelerator | |
| JP7751280B2 (en) | Collagen production promoter, MMP-2 inhibitor, cell proliferation promoter and internal medicine | |
| KR102803251B1 (en) | Composition for improving skin conditions comprising the extract of Allium ulleungense |